Study of SNX-5422 in TP53 Null Cancers

NCT02612285 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Recruitment very slow - study could not be enrolled

Conditions

Interventions

Sponsor

Esanex Inc.